| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Gross profit | 0.0 | -0.0 |
| Profit before tax | -0.7 | -0.5 |
| Net income | -0.7 | -0.5 |
| EPS (diluted, $ a share) | $-0.00 | $-0.00 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +1438.1% |
|---|---|
| Gross margin | 74.3% |
10-Q filed with the SEC, OTC: RDGL. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Vivos Inc: key numbers
- Share price
- $0.0405Close, Nov 16
- Market cap
- $20M
- Shares outstanding
- 494.74MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Vivos Inc
All →Vivos Capital Raise of $1.02M
Vivos Inc. completed a Regulation A+ offering of 12,500,000 shares of common stock for gross proceeds of $1.0 million. Additionally, the company issued warrants to purchase 25,000,000 shares to accredited investors for $25,000 and completed a warrant exchange for 8,000,000 shares of common stock.
- Value
- $1.02M
Vivos Capital Raise
Vivos Inc. entered into a Stock Purchase and Exchange Agreement with a member of its Board of Directors, Carl Cadwell, for the purchase of 250,000 shares of Series D Convertible Preferred Stock for $250,000. Additionally, the director exchanged 385,302 shares of Series C Preferred for an equal number of Series D shares, resulting in the elimination of the Series C class. The Series D shares have a conversion price of $0.08 per share.
- Counterparty
- Carl Cadwell
Vivos Other 8-K Filing
Vivos Inc. filed a Certificate of Designations to create a new class of Series D Convertible Preferred Stock, designating 1.0 million shares with a stated value of $1.00 per share. The filing authorizes the rights and preferences of the new security, including a conversion price of $0.08 per share and super-voting rights equivalent to 50 votes for every share of common stock issuable upon conversion. No shares were reported as issued or sold in this filing.
Vivos CEO Michael K. Korenko Buys $99.6K of Stock
Michael K. Korenko, CEO, bought 200,000 shares of Vivos Inc at $0.498 a share, worth $99.6K in total on Sep 30, 2026. Shares held after the trade: 11,635,090 (+1.7%).
- Value
- $99.6K
- Shares
- 200,000
- Price
- $0.4980
- Role
- CEO
- Holding change
- +1.7%
- Trade date
- Sep 30, 2026